What are the other organ system effects of promethazine and what toxic dose levels apply to a 60‑kg adult male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Promethazine Multi-System Effects and Toxic Dosing

Promethazine causes significant multi-organ system toxicity, with doses above 625 mg (approximately 10 mg/kg in a 60-kg adult) associated with a 42% probability of delirium, and the FDA-documented toxic range of 75-125 mg in children causing paradoxical hyperexcitability, while doses of 25-100 mg in adults can produce serious adverse effects across cardiovascular, respiratory, neurological, and local tissue systems. 1, 2

Organ System Effects

Central Nervous System

Promethazine acts as a phenothiazine with dopaminergic blockade and produces dose-dependent CNS effects 3, 4:

  • Sedation and cognitive impairment: Therapeutic doses (25-50 mg) cause significant psychomotor impairment equivalent to blood alcohol levels of 0.085% for 25 mg and 0.137% for 50 mg 5
  • Delirium: Occurs in 42% of overdose cases at median dose of 625 mg 2
  • Extrapyramidal effects: Range from restlessness to oculogyric crises, dystonic reactions 3
  • Neuroleptic malignant syndrome: Rare but life-threatening complication 3, 4
  • Paradoxical reactions: In children, single doses of 75-125 mg cause hyperexcitability and nightmares 1
  • Seizures: Rarely occur in overdose 1

Cardiovascular System

  • Hypotension: Most common cardiovascular effect due to alpha-adrenergic blockade 3, 4
  • Tachycardia: Heart rate >100 bpm occurs in 56% of overdose cases 2
  • Requires slow IV infusion (≤25 mg/min) to minimize hypotension risk 3

Critical caveat: Epinephrine is contraindicated for promethazine-induced hypotension as it may paradoxically worsen hypotension due to partial adrenergic blockade; use norepinephrine or phenylephrine instead 1

Respiratory System

  • Respiratory depression: Particularly when combined with opioids or benzodiazepines 3, 4
  • Requires dose reduction of concurrent narcotics by 25-50% and benzodiazepines by at least 50% 3, 1

Anticholinergic Effects

Due to antimuscarinic properties 3, 4:

  • Dry mouth
  • Fixed, dilated pupils
  • Flushing
  • Urinary retention
  • Gastrointestinal symptoms

Local Tissue Toxicity (Parenteral Administration)

FDA Black Box Warning for injectable form 1, 6:

  • Tissue necrosis
  • Gangrene
  • Thrombophlebitis
  • Severe tissue injury with inadvertent perivascular extravasation
  • Catastrophic limb-threatening injury with intra-arterial injection
  • Intraneuronal or perineuronal infiltration damage

Toxic Dose Levels for 60-kg Adult

Therapeutic Range

  • Standard dose: 12.5-25 mg IV (slowly) or 25-50 mg total as adjuvant 3
  • Maximum therapeutic: Up to 100 mg total dose has been used 4

Toxic Thresholds

Based on overdose data 2:

  • 250 mg: 31% probability of delirium
  • 500 mg: 42% probability of delirium
  • 625 mg (median toxic dose): 42% delirium incidence in overdose series
  • 1000 mg: 55% probability of delirium

Pediatric Toxic Doses

  • 75-125 mg: Paradoxical hyperexcitability and nightmares in children 1
  • Contraindicated in children <2 years due to respiratory depression risk 1

Overdose Clinical Presentation

Signs range from mild CNS depression to life-threatening toxicity 1:

Mild-Moderate:

  • Drowsiness, sedation
  • Hypotension
  • Tachycardia
  • Anticholinergic signs (dry mouth, mydriasis, flushing)

Severe:

  • Profound hypotension
  • Respiratory depression requiring ventilatory support
  • Unconsciousness
  • Delirium (most common serious effect at 42% incidence) 2
  • Hyperreflexia, hypertonia, ataxia
  • Extensor-plantar reflexes (Babinski sign)
  • Convulsions (rare)

Notably absent: No seizures, dysrhythmias, or deaths reported in the 199-patient overdose series 2

Key Clinical Pitfalls

  1. Combination with CNS depressants: Dramatically increases sedation and respiratory depression risk—mandates dose reduction of opioids by 25-50% 3, 1

  2. Epinephrine contraindication: Will worsen hypotension; use norepinephrine or phenylephrine instead 1

  3. IV administration technique: Must infuse slowly (≤25 mg/min) and ensure proper IV placement to avoid catastrophic tissue injury 3, 6

  4. Psychomotor impairment: Even therapeutic doses cause significant cognitive impairment equivalent to legal intoxication 5

  5. Charcoal benefit: Administration within 2 hours reduces delirium probability in predictable manner 2

  6. Plasma half-life: 9-16 hours means prolonged effects and monitoring requirements 3, 4

Related Questions

What dose of promethazine syrup (available as 6.25 mg per 5 mL or 15 mg per 5 mL) should be given to a child weighing 8.23 kg?
What is promethazine (a first‑generation antihistamine) and what are its indications, dosing, contraindications, and side effects?
What are the indications and recommended dosage of promethazine tablets?
In an adult patient who mistakenly received 100 mg intramuscular promethazine (Phenergan), what adverse effects and clinical signs should be monitored?
What is the optimal method for administering intravenous promethazine (Phenergan)?
Is it appropriate to use atomoxetine, bupropion, and methylphenidate together?
What is the appropriate management for a patient presenting with numbness over the dorsum of the left foot and the left lateral lower leg who experiences foot drop when standing?
What medication regimen should be prescribed for a psychotic patient who is hallucinating (seeing rats and snakes), self‑harm, not taking oral medications, and currently receiving haloperidol decanoate 100 mg intramuscular monthly injection?
How should I evaluate and manage an adult male on anxiety/depression medication who is now experiencing symptoms resembling attention‑deficit/hyperactivity disorder?
Is the current inhaler regimen (beclometasone/formoterol 100 µg/6 µg twice daily plus tiotropium 18 µg once daily) optimal for a 73‑year‑old patient with emphysema who has a normal respiratory rate and oxygen saturation of 97 % according to UK guidelines?
Should a 2 cm abscess be incised and drained?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.